General Principles of Classification
Pharmacological correction of cerebral blood flow is a critical task in neurology. Specialized medications are used for this purpose, categorized by two main criteria: mechanism of action and chemical origin. The primary distinguishing feature of this group is their ability to selectively target the cerebrovascular bed, effectively improving blood flow. Based on pharmacological analysis, they are divided into synthetic drugs (calcium antagonists) and agents derived from plant raw materials (alkaloids).
Calcium Channel Blockers (Calcium Antagonists)
Calcium channel blockers represent one of the most significant groups in this classification. Their therapeutic value is due to their pronounced tropism for cerebral vessels.
- Cinnarizine is a basic representative of the group that selectively affects cerebral hemodynamics.
- Nimodipine is a specific drug with distinct clinical indications. In clinical practice, it is positioned as the drug of choice for severe vascular catastrophes, specifically subarachnoid hemorrhage. Such hemorrhage causes vasospasm leading to ischemia. The main goal of prescribing nimodipine is the prevention of ischemic injury. The drug reliably reduces the severity of neurological deficits and lowers the risk of profound ischemic impairment.
Plant Alkaloid Derivatives
A significant portion of drugs improving cerebral hemodynamics are of botanical origin. Pharmacology actively utilizes alkaloids from two plant sources that, after laboratory modification, became effective medications:
- Derivatives of periwinkle alkaloids (Vinca minor). Extracts from this plant served as the basis for semi-synthetic drugs. The main representative is vinpocetine, a semi-synthetic agent actively used to normalize cerebral circulation.
- Ergot alkaloid derivatives. This group has a unique pharmacological profile. A representative that improves cerebral circulation is nicergoline. Its most important characteristic is the presence of $\alpha$-adrenolytic activity. It is important to understand the distinction: unlike other ergot derivatives traditionally used as antimigraine drugs, nicergoline is used specifically for the systemic improvement of cerebral blood flow.
Specific Drugs: Pathogenetic Therapy of Migraine
Within the classification of agents affecting cerebral circulation, a special place is occupied by drugs with specific clinical effects aimed at treating particular conditions. A prime example is migraine therapy.
- Sumatriptan is a potent pathogenetic agent for migraine attacks. Its mechanism of action differs fundamentally from drugs that simply improve blood flow. Migraines involve excessive pulsation of cerebral vessels, which serves as the source of intense pain. Sumatriptan selectively reduces this pathological pulsation, leading to the effective elimination of headaches.
Clinical Application: Summary
Analysis of pharmacological characteristics shows that drug selection strictly depends on the clinical objective. For basic blood flow improvement, cinnarizine or vinpocetine are used. In acute conditions accompanied by vasospasm and the risk of ischemia (subarachnoid hemorrhage), nimodipine is essential. To abort specific throbbing migraine pain, a pathogenetic approach using sumatriptan is required. Thus, the classification reflects not only chemical origin but also the strict therapeutic orientation of each agent.